No-reflow phenomenon and endothelial glycocalyx of microcirculation

Biochemistry Research International

Volumn , Issue , 2012, Pages

  Maksimenko, Alexander V ^a   Turashev, Askar D ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855605264     PISSN: 20902247     EISSN: 20902255     Source Type: Journal    
DOI: 10.1155/2012/859231     Document Type: Review

References (90)

1. Burns R. J., Gibbons R. J., Yi Q., CORE study investigations. The relationships left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis Journal of the American College of Cardiology 2002 39 30 36 (Pubitemid 34059858)
2. Kloner R. A., Forman M. B., Gibbons R. J., Ross A. M., Alexander R. W., Stone G. W., Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial European Heart Journal 2006 27 20 2400 2405 (Pubitemid 44522145)
3. Ross A. M., Gibbons R. J., Stone G. W., Kloner R. A., Alexander R. W., A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II) Journal of the American College of Cardiology 2005 45 11 1775 1780 (Pubitemid 40779856)
4. Kitakaze M., Asakura M., Kim J., Shintani Y., Asanuma H., Hamasaki T., Seguchi O., Myoishi M., Minamino T., Ohara T., Nagai Y., Nanto S., Watanabe K., Fukuzawa S., Hirayama A., Nakamura N., Kimura K., Fujii K., Ishihara M., Saito Y., Tomoike H., Kitamura S., Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials The Lancet 2007 370 9597 1483 1493 (Pubitemid 47625560)
5. Miura T., Miki T., Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapy Basic Research in Cardiology 2008 103 6 501 513
6. Maksimenko A. V., Thrombolysis researchnew objectives after a shift of accent Medical Science Monitor 2002 8 1 RA13 RA21
7. Maes A., Van de Werf F., Nuyts J., Bormans G., Desmet W., Mortelmans L., Impaired myocardial tissue perfusion early after successful thrombolysis: impact on myocardial flow, metabolism, and function at late follow-up Circulation 1995 92 8 2072 2078
8. Topol E. J., Acute myocardial infarction: thrombolysis Heart 2000 83 1 122 126 (Pubitemid 30307663)
9. Gibson C. M., Cannon C. P., Murphy S. A., Ryan K. A., Mesley R., Marble S. J., McCabe C. H., Van De Werf F., Braunwald E., Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs Circulation 2000 101 2 125 130 (Pubitemid 30044249)
10. French J. K., Ramanathan K., Stewart J. T., Gao W., Théroux P., White H. D., A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction American Heart Journal 2003 145 3 508 514 (Pubitemid 36390498)
11. Morrow D. A., de Lemos J. A., Assessing the success of fibrinolysis: can we let the interventionalist rest? American Heart Journal 2003 145 3 380 382 (Pubitemid 36390480)
12. Maes A. F., Van de Werf F., Mesotten L. V., Flamen P. B., Kuzo R. S., Nuyts J. L., Mortelmans L., Early assessment of regional myocardial blood flow and metabolism in thrombolysis in myocardial infarction flow grade 3 reperfused myocardial infarction using carbon-11-acetate Journal of the American College of Cardiology 2001 37 1 30 36 (Pubitemid 32051715)
13. Roe M. T., Ohman E. M., Maas A. C. P., Christenson R. H., Mahaffey K. W., Granger C. B., Harrington R. A., Califf R. M., Krucoff M. W., Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion Journal of the American College of Cardiology 2001 37 1 9 18 (Pubitemid 32051713)
14. den Uil C. A., Klijn E., Lagrand W. K., Brugts J. J., Ince C., Spronk P. E., Simoons M. L., The microcirculation in health and critical disease Progress in Cardiovascular Diseases 2008 51 2 161 170
15. Jaffe R., Charron T., Puley G., Dick A., Strauss B. H., Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention Circulation 2008 117 24 3152 3156
16. Chappel D., Hoffman-Kiefer K., Jacob M., TNF- induced shedding of endothelial glycocalyx is prevented by hydrocortisone and antithrombin Basic Research in Cardiology 2008 104 78 89
17. Bramos D., Ikonomidis I., Tsirikos N., Kottis G., Kostopoulou V., Pamboucas C., Papadopoulou E., Venetsanou K., Giatrakos N., Yang G. Z., Nihoyannopoulos P., Toumanidis S., The association of coronary flow changes and inflammatory indices to ischaemia-reperfusion microvascular damage and left ventricular remodelling Basic Research in Cardiology 2008 103 4 345 355
18. Hirsch A., Nijveldt R., Haeck J. D. E., Beek A. M., Koch K. T., Henriques J. P. S., van der Schaaf R. J., Vis M. M., Baan J., de Winter R. J., Tijssen J. G. P., van Rossum A. C., Piek J. J., Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction Journal of the American College of Cardiology 2008 51 23 2230 2238 (Pubitemid 351754995)
19. Reffelmann T., Kloner R. A., The no-reflow phenomenon: a basic mechanism of myocardial ischemia and reperfusion Basic Research in Cardiology 2006 101 5 359 372 (Pubitemid 44275869)
20. Abbate A., Bussani R., Sinagra G., Barresi E., Pivetta A., Perkan A., Hoke N. H., Salloum F. N., Kontos M. C., Biondi-Zoccai G. G. L., Vetrovec G. W., Sabbadini G., Baldi F., Silvestri F., Kukreja R. C., Baldi A., Right ventricular cardiomyocyte apoptosis in patients with acute myocardial infarction of the left ventricular wall American Journal of Cardiology 2008 102 6 658 662
21. Galiuto L., Crea F., No-reflow: a heterogeneous clinical phenomenon with multiple therapeutic strategies Current Pharmaceutical Design 2006 12 29 3807 3815 (Pubitemid 44560714)
22. Niccoli G., Giubilato S., Russo E., Spaziani C., Leo A., Porto I., Leone A. M., Burzotta F., Riondino S., Pulcinelli F., Biasucci L. M., Crea F., Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention European Heart Journal 2008 29 15 1843 1850
23. Bse D., von Birgelen C., Zhou X. Y., Schmermund A., Philipp S., Sack S., Konorza T., Mhlenkamp S., Leineweber K., Kleinbongard P., Wijns W., Heusch G., Erbel R., Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions Basic Research in Cardiology 2008 103 6 587 597
24. Bijnens B., Sutherland G. R., Myocardial oedema: a forgotten entity essential to the understanding of regional function after ischaemia or reperfusion injury Heart 2008 94 9 1117 1119
25. Ikeno F., Inagaki K., Rezaee M., Mochly-Rosen D., Impaired perfusion after myocardial infarction is due to reperfusion-induced deltaPKC-mediated myocardial damage Cardiovascular Research 2007 73 4 699 709 (Pubitemid 46227353)
26. Wilson G. J., Diaz R. J., The myocardial no-reflow phenomenon: role of deltaPKC Cardiovascular Research 2007 73 4 623 625 (Pubitemid 46227359)
27. Zalewski J., Undas A., Godlewski J., Stepien E., Zmudka K., No-reflow phenomenon after acute myocardial infarction is associated with reduced clot permeability and susceptibility to lysis Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 10 2258 2265 (Pubitemid 350287258)
28. Nicolli G., Burzotta F., Galuito L., Crea F., Myocardial no-reflow in humans Journal of the American College of Cardiology 2009 54 281 292
29. Maksimenko A. V., Effects of glycosaminoglycans in vascular events Pharmaceutical Chemistry Journal 2008 42 10 553 563
30. Cabrales P., Vzquez B. Y., Tsai A. G., Intaglietta M., Microvascular and capillary perfusion following glycocalyx degradation Journal of Applied Physiology 2007 102 6 2251 2259 (Pubitemid 47080757)
31. Long D. S., Smith M. L., Pries A. R., Ley K., Damiano E. R., Microviscometry reveals reduced blood viscosity and altered shear rate and shear stress profiles in microvessels after hemodilution Proceedings of the National Academy of Sciences of the United States of America 2004 101 27 10060 10065 (Pubitemid 38891194)
32. Vink H., Duling B. R., Capillary endothelial surface layer selectively reduces plasma solute distribution volume American Journal of Physiology 2000 278 1 H285 H289
33. Platts S. H., Duling B. R., Adenosine A3 receptor activation modulates the capillary endothelial glycocalyx Circulation Research 2004 94 1 77 82 (Pubitemid 38064101)
34. Broekhuizen L. N., Mooij H. L., Kastelein J. J. P., Stroes E. S. G., Vink H., Nieuwdorp M., Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease Current Opinion in Lipidology 2009 20 1 57 62
35. Nieuwdorp M., Meuwese M. C., Vink H., Hoekstra J. B. L., Kastelein J. J. P., Stroes E. S. G., The endothelial glycocalyx: a potential barrier between health and vascular disease Current Opinion in Lipidology 2005 16 5 507 511 (Pubitemid 41376899)
36. Reitsma S., Slaaf D. W., Vink H., van Zandvoort M. A. M. J., Oude Egbrink M. G. A., The endothelial glycocalyx: composition, functions, and visualization Pflger's Archiv 2007 454 3 345 359 (Pubitemid 46742429)
37. Huxley V. H., Williams D. A., Role of a glycocalyx on coronary arteriole permeability to proteins: evidence from enzyme treatments American Journal of Physiology 2000 278 4 H1177 H1185
38. Platts S. H., Linden J., Duling B. R., Rapid modification of the glycocalyx caused by ischemia-reperfusion is inhibited by adenosine A2A receptor activation American Journal of Physiology 2003 284 6 H2360 H2367
39. Mulivor A. W., Lipowsky H. H., Inflammation- and ischemia-induced shedding of venular glycocalyx American Journal of Physiology 2004 286 5 H1672 H1680
40. Bruegger D., Rehm M., Jacob M., Chappell D., Stoeckelhuber M., Welsch U., Conzen P., Becker B. F., Exogenous nitric oxide requires an endothelial glycocalyx to prevent postischemic coronary vascular leak in guinea pig hearts Critical Care 2008 12 3, article R73
41. Patel K. N., Soubra S. H., Bellera R. V., Dong J. F., McMullen C. A., Burns A. R., Rumbaut R. E., Differential role of von Willebrand factor and P-selectin on microvascular thrombosis in endotoxemia Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 12 2225 2230
42. van den Berg B. M., Vink H., Spaan J. A. E., The endothelial glycocalyx protects against myocardial edema Circulation Research 2003 92 6 592 594 (Pubitemid 36417691)
43. Rehm M., Bruegger D., Christ F., Conzen P., Thiel M., Jacob M., Chappell D., Stoeckelhuber M., Welsch U., Reichart B., Peter K., Becker B. F., Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia Circulation 2007 116 17 1896 1906 (Pubitemid 350287085)
44. Sarembock I. J., From systemic shotgun to site-specific nanoparticle-targeted delivery a new paradigm for drug delivery Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 11 1879 1881
45. Joner M., Morimoto K., Kasukawa H., Steigerwald K., Merl S., Nakazawa G., John M. C., Finn A. V., Acampado E., Kolodgie F. D., Gold H. K., Virmani R., Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 11 1960 1966
46. Harigai T., Kondo M., Isozaki M., Kasukawa H., Hagiwara H., Uchiyama H., Kimura J., Preferential binding of polyethylene glycol-coated liposomes containing a novel cationic lipid, TRX-20, to human subendthelial cells via chondroitin sulfate Pharmaceutical Research 2001 18 9 1284 1290 (Pubitemid 32846321)
47. Dabbas S., Kaushik R. R., Dandamudi S., Kuesters G. M., Campbell R. B., Importance of the liposomal cationic lipid content and type in tumor vascular targeting: physicochemical characterization and in vitro studies using human primary and transformed endothelial cells Endothelium 2008 15 4 189 201
48. Schneider D. J., Sobel B. E., A novel role for tissue-type plasminogen activator prevention of thromboembolic occlusion Circulation 2008 118 14 1408 1409
49. Danielyan K., Ganguly K., Ding B. S., Atochin D., Zaitsev S., Murciano J. C., Huang P. L., Kasner S. E., Cines D. B., Muzykantov V. R., Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator Circulation 2008 118 14 1442 1449
50. Ganguly K., Murciano J. C., Westrick R., Leferovich J., Cines D. B., Muzykantov V. R., The glycocalyx protects erythrocyte-bound tissue-type plasminogen activator from enzymatic inhibition Journal of Pharmacology and Experimental Therapeutics 2007 321 1 158 164 (Pubitemid 46456958)
51. Squire J. M., Chew M., Nneji G., Neal C., Barry J., Michel C., Quasi-periodic substructure in the microvessel endothelial glycocalyx: a possible explanation for molecular filtering? Journal of Structural Biology 2001 136 3 239 255
52. Golovanov M. V., Bauer J., Electron microscopic characterization of gels formed by blood cells of leukemia patients at hypertonicity Colloids and Surfaces B 2005 44 4 167 171 (Pubitemid 44302090)
53. Golovanov M. V., Biophysical structure of upper layer of tumor cell plasmatic membrane (glycocalyx) N. N. Blokhin Russian Cancer Research Center RAMS 2006 17 4 6
54. Weinbaum S., Zhang X., Han Y., Vink H., Cowin S. C., Mechanotransduction and flow across the endothelial glycocalyx Proceedings of the National Academy of Sciences of the United States of America 2003 100 13 7988 7995 (Pubitemid 36760082)
55. Evanko S. P., Tammi M. I., Tammi R. H., Wight T. N., Hyaluronan-dependent pericellular matrix Advanced Drug Delivery Reviews 2007 59 13 1351 1365 (Pubitemid 350088257)
56. Evanko S. P., Wight T. N., Intracellular localization of hyaluronan in proliferating cells Journal of Histochemistry and Cytochemistry 1999 47 10 1331 1342
57. Evanko S. P., Parks T. T., Wight T. N., Intracellular hyaluronan in arterial smooth muscle cells: association with microtubules, RHAMM, and the mitotic spindle Journal of Histochemistry and Cytochemistry 2004 52 12 1525 1535 (Pubitemid 39603252)
58. Kaverina I., Krylyshkina O., Small J. V., Microtubule targeting of substrate contacts promotes their relaxation and dissociation Journal of Cell Biology 1999 146 5 1033 1044
59. Van der Heiden K., Hierck B. P., Krams R., de Crom R., Cheng C., Baiker M., Pourquie M. J. B. M., Alkemade F. E., DeRuiter M. C., Gittenberger-de Groot A. C., Poelmann R. E., Endothelial primary cilia in areas of disturbed flow are at the base of atherosclerosis Atherosclerosis 2008 196 2 542 550
60. Nauli S. M., Kawanabe Y., Kaminski J. J., Pearce W. J., Ingber D. E., Zhou J., Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1 Circulation 2008 117 9 1161 1171 (Pubitemid 351544064)
61. Poelmann R. E., Van der Heiden K., Gittenberger-De Groot A., Hierck B. P., Deciphering the endothelial shear stress sensor Circulation 2008 117 9 1124 1126 (Pubitemid 351544055)
62. Florian J. A., Kosky J. R., Ainslie K., Pang Z., Dull R. O., Tarbell J. M., Heparan sulfate proteoglycan is a mechanosensor on endothelial cells Circulation Research 2003 93 10 e136 e142
63. Pahakis M. Y., Kosky J. R., Dull R. O., Tarbell J. M., The role of endothelial glycocalyx components in mechanotransduction of fluid shear stress Biochemical and Biophysical Research Communications 2007 355 1 228 233 (Pubitemid 46273392)
64. Weinbaum S., Tarbell J. M., Damiano E. R., The structure and function of the endothelial glycocalyx layer Annual Review of Biomedical Engineering 2007 9 121 167 (Pubitemid 350246654)
65. Lopez-Quintero S. V., Amaya R., Pahakis M., Tarbell J. M., The endothelial glycocalyx mediates shear-induced changes in hydraulic conductivity American Journal of Physiology 2009 296 5 H1451 H1456
66. Slevin M., Krupinski J., Gaffney J., Matou S., West D., Delisser H., Savani R. C., Kumar S., Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways Matrix Biology 2007 26 1 58 68 (Pubitemid 46091650)
67. Stern R., Kogan G., Jedrzejas M. J., Soltés L., The many ways to cleave hyaluronan Biotechnology Advances 2007 25 6 537 557 (Pubitemid 47464847)
68. Stevens A. P., Hlady V., Dull R. O., Fluorescence correlation spectroscopy can probe albumin dynamics inside lung endothelial glycocalyx American Journal of Physiology 2007 293 2 L328 L335
69. Gao F., Koenitzer J. R., Tobolewski J. M., Jiang D., Liang J., Noble P. W., Oury T. D., Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan Journal of Biological Chemistry 2008 283 10 6058 6066
70. Camaioni A., Hascall V. C., Yanagishita M., Salustri A., Effects of exogenous hyaluronic acid and serum on matrix organization and stability in the mouse cumulus cell-oocyte complex Journal of Biological Chemistry 1993 268 27 20473 20481 (Pubitemid 23278958)
71. Sugahara K. N., Murai T., Nishinakamura H., Kawashima H., Saya H., Miyasaka M., Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells Journal of Biological Chemistry 2003 278 34 32259 32265 (Pubitemid 37048419)
72. Chajara A., Raoudi M., Delpech B., Levesque H., Inhibition of arterial cells proliferation in vivo in injured arteries by hyaluronan fragments Atherosclerosis 2003 171 1 15 19 (Pubitemid 37464625)
73. Chung I. M., Gold H. K., Schwartz S. M., Ikari Y., Reidy M. A., Wight T. N., Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment Journal of the American College of Cardiology 2002 40 12 2072 2081 (Pubitemid 36005890)
74. Verheye S., Markou C. P., Salame M. Y., Wan B., King S. B., Robinson K. A., Chronos N. A. F., Hanson S. R., Reduced thrombus formation by hyaluronic acid coating of endovascular devices Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 4 1168 1172 (Pubitemid 30207598)
75. Mitsi M., Forsten-Williams K., Gopalakrishnan M., Nugent M. A., A catalytic role of heparin within the extracellular matrix Journal of Biological Chemistry 2008 283 50 34796 34807
76. Cska T. B., Frost G. I., Stern R., Hyaluronidases in tissue invasion Invasion and Metastasis 1997 17 6 297 311 (Pubitemid 29082188)
77. Grimsrud P. A., Xie H., Griffin T. J., Bernlohr D. A., Oxidative stress and covalent modification of protein with bioactive aldehydes Journal of Biological Chemistry 2008 283 32 21837 21841
78. Goldin A., Beckman J. A., Schmidt A. M., Creager M. A., Advanced glycation end products: sparking the development of diabetic vascular injury Circulation 2006 114 6 597 605 (Pubitemid 44199649)
79. Shapiro B. P., Owan T. E., Mohammed S. F., Meyer D. M., Mills L. D., Schalkwijk C. G., Redfield M. M., Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines Circulation 2008 118 10 1002 1010
80. Zhang M., Kho A. L., Anilkumar N., Chibber R., Pagano P. J., Shah A. M., Cave A. C., Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: involvement of Nox2 (gp91phox)-containing NADPH oxidase Circulation 2006 113 9 1235 1243
81. Bucciarelli L. G., Kaneko M., Ananthakrishnan R., Harja E., Lee L. K., Hwang Y. C., Lerner S., Bakr S., Li Q., Lu Y., Song F., Qu W., Gomez T., Yu S. Z., Shi F. Y., Schmidt A. M., Ramasamy R., Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury Circulation 2006 113 9 1226 1234
82. Basta G., Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications Atherosclerosis 2008 196 1 9 21
83. Garud D. R., Tran V. M., Victor X. V., Koketsu M., Kuberan B., Inhibition of heparan sulfate and chondroitin sulfate proteoglycan biosynthesis Journal of Biological Chemistry 2008 283 43 28881 28887
84. Jaffer F. A., Libby P., Weissleder R., Molecular imaging of cardiovascular disease Circulation 2007 116 9 1052 1061 (Pubitemid 47329570)
85. Knaapen P., Camici P. G., Marques K. M., Nijveldt R., Bax J. J., Westerhof N., Gtte M. J. W., Jerosch-Herold M., Schelbert H. R., Lammertsma A. A., van Rossum A. C., Coronary microvascular resistance: methods for its quantification in humans Basic Research in Cardiology 2009 104 5 485 498
86. Nieuwdorp M., Meuwese M. C., Mooij H. L., Ince C., Broekhuizen L. N., Kastelein J. J. P., Stroes E. S. G., Vink H., Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability Journal of Applied Physiology 2008 104 3 845 852 (Pubitemid 351468815)
87. Abdel-Aty H., Cocker M., Meek C., Tyberg J. V., Friedrich M. G., Edema as a very early marker for acute myocardial ischemia Journal of the American College of Cardiology 2009 53 14 1194 1201
88. Megens R. T. A., Reitsma S., Schiffers P. H. M., Hilgers R. H. P., De Mey J. G. R., Slaaf D. W., Oude Egbrink M. G. A., Van Zandvoort M. A. M. J., Two-photon microscopy of vital murine elastic and muscular arteries: combined structural and functional imaging with subcellular resolution Journal of Vascular Research 2007 44 2 87 98
89. van Zandvoort M., Engels W., Douma K., Beckers L., Oude Egbrink M., Daemen M., Slaaf D. W., Two-photon microscopy for imaging of the (atherosclerotic) vascular wall: a proof of concept study Journal of Vascular Research 2004 41 1 54 63 (Pubitemid 38296300)
90. Noble M. I. M., Drake-Holland A. J., Vink H., Hypothesis: arterial glycocalyx dysfunction is the first step in the atherothrombotic process QJM 2008 101 7 513 518 (Pubitemid 351911993)